Congressmen eye Caremark, CVS for inquiry

"Eight U.S. congressmen joined a push for the Federal Trade Commission to re-examine CVS Corp.'s acquisition of Caremark Rx, Inc. in 2007," Bloomberg reports. The deal combined one of the nations' largest pharmacy chains with a major pharmacy-benefits manager to create the biggest purchaser of generic drugs in the country. That move, say unions, community groups and lawmakers, including five senators, could be anti-competitive and could hurt consumers, patients and other companies (Wolf, 9/16).

This is part of Kaiser Health News' Daily Reports - a summary of health policy coverage from more than 300 news organizations. The full summary of the day's news can be found here and you can sign up for e-mail subscriptions to the Daily Reports here. In addition, our staff of reporters and correspondents file original stories each day, which you can find on our home page.

---

This article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.